Idexx Laboratories Inc (IDXX)
Idexx Laboratories Inc is a global provider of veterinary diagnostics, software, and services for animal health. The company develops testing solutions to help veterinarians diagnose and monitor health conditions in animals, including in-clinic diagnostic instruments, laboratory diagnostic services, and veterinarian practice management software. Founded in 1983, Idexx has established itself as a leading innovator in veterinary medical diagnostics and animal health solutions.
Company News
Idexx Laboratories reported strong Q3 2025 financial results, with revenue growing 13% to $1.11 billion and net income rising 18%. The company beat analyst expectations and raised its full-year guidance, leading to a significant stock price increase.
Wall Street opened mixed on Monday, with AI-driven mega-cap stocks rallying while broader markets remained cautious. Nvidia and Amazon saw significant gains, while cryptocurrencies experienced notable declines.
The veterinary oncology market is projected to grow from $1.84 billion in 2025 to $3.55 billion by 2030, driven by technological advances, rising pet ownership, and increasing demand for advanced cancer treatments in veterinary medicine.
IDEXX's (IDXX) supply chain operations bear the brunt of geopolitical instability, including the current war in Ukraine.
